Vasundhara Rasayans Limited (BOM:538634)
India · Delayed Price · Currency is INR 130.85
+0.35 (0.27%)
At close: May 8, 2026
Vasundhara Rasayans Market Cap
Vasundhara Rasayans has a market cap or net worth of 415.87 million as of May 8, 2026. Its market cap has decreased by -45.10% in one year.
Market Cap
415.87M
Enterprise Value
414.54M
Revenue
315.86M
Ranking
n/a
PE Ratio
11.19
Stock Price
130.85
Market Cap Chart
Since January 13, 2015, Vasundhara Rasayans's market cap has increased from 41.32M to 415.87M, an increase of 906.54%. That is a compound annual growth rate of 22.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 415.87M | -23.07% |
| Dec 31, 2025 | 540.61M | -41.45% |
| Dec 31, 2024 | 923.27M | 47.09% |
| Dec 29, 2023 | 627.69M | 50.94% |
| Dec 30, 2022 | 415.87M | -3.86% |
| Dec 31, 2021 | 432.55M | 69.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tyche Industries | 1.38B |
| Smruthi Organics | 1.38B |
| Krebs Biochemicals & Industries | 1.29B |
| Resonance Specialties | 1.26B |
| Bacil Pharma | 817.12M |
| Alfavision Overseas (India) | 418.35M |
| Crestchem | 371.70M |
| Venmax Drugs and Pharmaceuticals | 277.99M |